Invention Grant
- Patent Title: Heterocyclic indazole derivatives
- Patent Title (中): 杂环吲唑衍生物
-
Application No.: US12600060Application Date: 2008-04-18
-
Publication No.: US08334309B2Publication Date: 2012-12-18
- Inventor: Markus Klein , Norbert Beier
- Applicant: Markus Klein , Norbert Beier
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
- Current Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: DE102007022565 20070514
- International Application: PCT/EP2008/003143 WO 20080418
- International Announcement: WO2008/138448 WO 20081120
- Main IPC: A61K31/41
- IPC: A61K31/41 ; A61K31/33 ; A01N43/82 ; A01N43/00 ; A01N43/64 ; C07D271/06 ; C07D271/12 ; C07D413/00 ; C07D498/00 ; C07D249/14
Abstract:
Novel heterocyclic indazole derivatives of the formula (I), in which L, Q, R, X, Y, R3, R4 and R5 have the meanings indicated in Claim 1, are SGK inhibitors and can be used for the treatment of SGK-induced diseases and complaints, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, generally in fibroses and inflammatory processes of any type.
Public/Granted literature
- US20110190355A1 HETEROCYCLIC INDAZOLE DERIVATIVES Public/Granted day:2011-08-04
Information query
